| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 6.14× | 6.14× | 6.23× | 5.87× | 7.12× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 0.15× | 0.15× | 0.16× | 0.17× | 0.17× | ||
| — | — | −8.19× | −7.01× | −4.99× | ||
| — | — | −1.96× | −2.00× | −3.23× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 7.12 | 5.87 | 6.23 | 6.14 | 6.14 | |
| Asset Turnover | 0.17 | 0.17 | 0.16 | 0.15 | 0.15 | |
| Cash Conversion (CFO/Net Income) | -4.99 | -7.01 | -8.19 | — | — | |
| CFO/EBITDA | -3.23 | -2.00 | -1.96 | — | — |